KIN - Kindred Biosciences - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $4.41. This is a potential upside of $4.41 (0%) from yesterday's end of day stock price of $0.

Kindred Biosciences's activity chart (see below) currently has 21 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.17% with an average time for these price targets to be met of 189.88 days.

Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 23-Aug-2021. First documented stock forecast 17-Nov-2015.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

15.25

2 years 8 months ago

2/4 (50%)

$10.95 (254.65%)

332

Hold

2 years 10 months 6 days ago

2/4 (50%)

$4.96 (35.33%)

30

Hold

9

$-0.25 (-2.70%)

12

2 years 10 months 7 days ago

0/4 (0%)

$6.82 (88.53%)

Hold

9.25

11

2 years 10 months 7 days ago

1/5 (20%)

$0.02 (0.22%)

69

Hold

9

$-0.25 (-2.70%)

2 years 10 months 8 days ago

0/2 (0%)

$3.3 (36.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KIN (Kindred Biosciences) average time for price targets to be met?

On average it took 189.88 days on average for the stock forecasts to be realized with a an average price target met ratio 44.17

Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?

ALEX ARFAEI

Which analyst has the current lower performing score on KIN (Kindred Biosciences) with a proven track record?

NATHAN WEINSTEIN

Which analyst has the most public recommendations on KIN (Kindred Biosciences)?

Alex Arfaei has 10 price targets and 9 ratings on KIN

Which analyst is the currently most bullish on KIN (Kindred Biosciences)?

Swayampakula Ramakanth with highest potential upside - $0

Which analyst is the currently most reserved on KIN (Kindred Biosciences)?

Alex Arfaei with lowest potential downside - -$4.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?